Related Experiment Video

Updated: May 10, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

Diffuse lung disease in children: summary of a scientific conference

Aaron Hamvas1, Robin Deterding, William E Balch

  • 1Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, Missouri.

Pediatric Pulmonology
|June 27, 2013
PubMed

Insights

This conference summarized advances in understanding childhood diffuse lung disease (DLD). Experts reviewed genetics, stem cells, and regenerative medicine for pediatric DLD.

Area of Science:

  • Pediatric Pulmonology
  • Translational Medicine
  • Rare Diseases

Background:

  • Diffuse lung disease (DLD) in children presents complex diagnostic and therapeutic challenges.
  • A multi-disciplinary approach is crucial for advancing the understanding and treatment of pediatric DLD.
  • Existing knowledge gaps necessitate a review of recent scientific developments and emerging concepts.

Purpose of the Study:

  • To convene experts in pediatric diffuse and interstitial lung diseases.
  • To review recent scientific developments and emerging concepts in the pathophysiology of childhood DLD.
  • To discuss translational approaches and novel therapeutic strategies.

Main Methods:

  • Summary of presentations from a multi-disciplinary scientific conference held in June 2012.
  • Inclusion of perspectives from clinicians, researchers, government representatives, and patient advocates.
  • Focus on translational research, including genetics, proteomics, epigenetics, and regenerative medicine.

Main Results:

  • Discussion of genetics and proteomics in understanding DLD.
  • Exploration of epigenetics and epigenomics in pediatric lung disease.
  • Review of DLD models, including animal models and induced pluripotent stem cells.
  • Consideration of regenerative medicine approaches for DLD treatment.

Conclusions:

  • The conference highlighted the importance of multi-disciplinary collaboration in pediatric DLD research.
  • Translational research, encompassing genetics, epigenetics, and stem cell technology, shows promise for DLD.
  • Regenerative medicine offers potential future therapeutic avenues for children with diffuse lung disease.

Keywords:
childhood interstitial lung diseasediffuse lung diseaseepigeneticsgeneticsstem cell

More Related Videos

Breath Collection from Children for Disease Biomarker Discovery06:09

Breath Collection from Children for Disease Biomarker Discovery

Published on: February 14, 2019

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...